Hahn Defends Using Less ‘Robust’ Data During COVID, But Critics Contend It Has Gone Too Far

 
• By Sarah Karlin-Smith
Stephen Hahn of MD Anderson Cancer Center is expected to be nominated for FDA commissioner
FDA Commissioner Stephen Hahn gave an update on the agency's COVID-19 efforts this week

More from US FDA

More from Agency Leadership